Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Acute Lymphoblastic Leukemia (B-ALL)
Clinical trial NCT02669264 · TERMINATED
Trial details
- NCT number
- NCT02669264
- Sponsor
- ADC Therapeutics S.A.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2018-07-03
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.